12th June, 2017, BusinessOptix a leading provider of business modelling and process design tools, today announces that Gartner acknowledges it as a representative vendor in the recent Market Guide for Enterprise Business Process Analysis (EBPA)*.
According to Gartner, “By its unique business operating model approach and its cloud-first focus, BusinessOptix has become very appealing to large consulting and system integration, business process outsourcing and end-user organizations that are creating process excellence and intellectual property on the platform.”
“Over the past year we have continued to develop our platform to meet the needs of organisations transforming and improving their business operations,” said Peter McInally, CEO, BusinessOptix. “Client initiatives and successes over the past 12 months illustrate the value of a single platform that meets the end-to-ends of all stakeholders involved in business operations.”
Today, BusinessOptix is being used by clients and partners to transform and improve their business operations in industries such as financial services, health, utilities, automotive, manufacturing and government.
BusinessOptix cloud-based platform enables organizations to transform and improve their business operations. BusinessOptix has a simple to use and intuitive interface that includes the ability to create, collaborate, publish, manage and reuse models, processes and data – all on a single platform.
For more information, visit: www.businessoptix.com.
Press Contact: email@example.com
* Gartner, Inc. "Market Guide for Enterprise Business Process Analysis" by Marc Kerremans and Samantha Searle, 7th June, 2017
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.